-
公开(公告)号:US20240269258A1
公开(公告)日:2024-08-15
申请号:US18627824
申请日:2024-04-05
申请人: SANOFI PASTEUR INC.
发明人: Timothy ALEFANTIS , Mario BARRO , Anthony BYERS , Philip DAVIDSON , Maryann GIEL-MOLONEY , Philippe-Alexandre GILBERT , Harold KLEANTHOUS , Armaghan NAIK , Konstantin PUGACHEV , Saranya SRIDHAR , William WARREN , Konstantin ZELDOVICH
IPC分类号: A61K39/145 , A61K9/00 , A61K39/00 , C07K14/005
CPC分类号: A61K39/145 , A61K9/0019 , C07K14/005 , A61K2039/55555 , A61K2039/70 , C12N2760/16322 , C12N2760/16334
摘要: Disclosed are multivalent vaccine or immunogenic compositions comprising influenza virus hemagglutinin (HA) from standard of care influenza virus strains, or ribonucleic acid molecules encoding the same; and one or more influenza virus HA identified or designed by machine learning, or one or more ribonucleic acid molecules that encode the influenza virus HA identified or designed by machine learning. Also disclosed are methods of using the vaccine or immunogenic compositions.
-
2.
公开(公告)号:US20240277828A1
公开(公告)日:2024-08-22
申请号:US18653422
申请日:2024-05-02
申请人: SANOFI PASTEUR INC
发明人: Timothy ALEFANTIS , Mario BARRO , Anthony BYERS , Guadalupe CORTES-GARCIA , Philippe-Alexandre GILBERT , Harold KLEANTHOUS , Armaghan NAIK , Konstantin PUGACHEV , Saranya SRIDHAR , Thorsten VOGEL , William WARREN
IPC分类号: A61K39/145 , A61K39/00 , A61P37/04
CPC分类号: A61K39/145 , A61P37/04 , A61K2039/54 , A61K2039/545 , A61K2039/55555 , A61K2039/55566 , A61K2039/70
摘要: Disclosed herein are multivalent vaccine or immunogenic compositions comprising one or more recombinant influenza virus hemagglutinin (HA), one or more recombinant influenza virus neuraminidase (NA), and an optional adjuvant. Also disclosed are methods of using the vaccine or immunogenic composition.
-
公开(公告)号:US20210128715A1
公开(公告)日:2021-05-06
申请号:US17041784
申请日:2019-03-27
申请人: SANOFI PASTEUR INC.
发明人: Tod STRUGNELL , Eliud OLOO , Raymond OOMEN , Thorsten VOGEL , Harold KLEANTHOUS
IPC分类号: A61K39/145 , C07K14/11 , A61P31/16
摘要: The present disclosure relates to a cluster-based consensus approach for generating recombinant hemagglutinin (HA) polypeptides. The disclosure further relates to influenza vaccine compositions comprising the recombinant HA polypeptides.
-
-